TI/
Editorial Board

Editorial Board

  • Editor-in-Chief

    • Prof.  Francesco M. Marincola

      • 1. TAM Biosciences, Boston, MA, USA
      • 2. TAM Global, Nashville, TN, USA.
      Research Interests:
      translational medicine; tumor immunology; immunotherapy; cell therapy.
      avatar img

  • Executive Editor-in-Chief

    • Prof.  Yang Liang

      Department of Hematological Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China.

      Research Interests:
      pathogenesis of myeloid malignancies; immune model and immune treatment for hematological cancer.
      avatar img

  • Editorial Board Members

    • Prof.  Weijie Cao

      Deputy Director of the Department of Hematology, Director of the Hematopoietic Stem Cell Transplantation Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

      Research Interests:
      hematopoietic stem cell transplantation (especially in adverse-risk AML/MDS, SAA, ALL); clinacal and translational research in infectious diseases in hematological diseases; research on erythropoiesis after hematopoietic stem cell transplantation).
      avatar img

    • Dr.  Boro Dropulić

      Executive Director of Caring Cross, Gaithersburg, MD, USA.

      Research Interests:
      gene therapy.
      avatar img

    • Prof.  Xiaosheng Fang

      Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong, China.

      Research Interests:
      stem cell transplantation; leukemia.
      avatar img

    • Prof.  Guangxun Gao

      Department of Hematology, Xijing Hospital, Air Force Medical University, Xi'an, China.

      Research Interests:
      targeted therapy and immunotherapy for hematological malignancies such as multiple myeloma; lymphoma and leukemia; CAR-T cell therapy; diagnosis and treatment of rare plasma cell diseases (e.g., POEMS syndrome, amyloidosis).
      avatar img

    • Prof.  Tiejun Gong

      Institute of Harbin Hematology and Oncology, The First Hospital of Harbin, Harbin, China.

      Research Interests:
      clinical and translational study of hematology.
      avatar img

    • Prof.  Weiwei Tian

      Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Shanxi, China.

      Research Interests:
      immunotherapy for malignant hematologic diseases.
      avatar img

    • Prof.  Sanbin Wang

      Department of Hematology, 920th Hospital of Joint Logistics Support Force, Yunnan 650100, China.

      Research Interests:
      hematopoietic stem cell transplantation; CAR-T Therapy; gene therapy for rare diseases, etc.
      avatar img

    • Prof.  Yingchi Zhang

      State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.

      Research Interests:
      pathogenesis and therapeutic strategies of drug-resistant and relapsed pediatric hematologic diseases; cellular immunotherapy.
      avatar img